No definition available.
Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)
C3_KIDNEY_CLEAR_CELL_CARCINOMA_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
1549 |
4. Check minimum number of eventsNone |
1549 |
5. Include endpointsNone |
1549 |
6. Filter based on genotype QC (FinnGen only) |
1549 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Clear cell adenocarcinoma of kidney
- Malignant neoplasm of kidney, except renal pelvis
- Malignant neoplasm of urinary organs
- Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1549 | 589 | 960 |
| Unadjusted period prevalence (%) | 0.34 | 0.20 | 0.42 |
| Median age at first event (years) | 67.78 | 68.40 | 67.40 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1406
- Matched controls
- 14060
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
JN4AD
NOMESCO Finland
Body CT examination
36.8
323.0
502
209
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
323.0
1347
*
KAC11
NOMESCO Finland
Total nephrectomy with capsule, transcutaneous
3174.6
323.0
413
*
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
323.0
1406
*
130
Kela drug reimbursment
Malignant tumour
+∞
323.0
367
*
KAC10
NOMESCO Finland
Total nephrectomy with capsule
1421.3
323.0
328
*
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
879.6
323.0
1067
50
B01AB10
ATC
tinzaparin; parenteral
22.2
300.6
459
300
JN4BD
NOMESCO Finland
Extensive body CT
20.7
294.7
462
324
WX302
NOMESCO Finland
Thoracal epidural anesthesy
38.1
266.5
343
118
JN4CD
NOMESCO Finland
Very extensive body CT
46.8
249.3
306
83
C64
ICD-10 Finland
Malignant neoplasm of kidney, except renal pelvis
+∞
245.1
228
*
KAD01
NOMESCO Finland
Percutaneous endoscopic partial nephrectomy
647.7
228.4
220
*
KAD00
NOMESCO Finland
Partial nephrectomy
483.3
213.6
208
5
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
17.9
210.3
344
250
197
Kela drug reimbursment
Sunitinib
+∞
198.8
186
*
TPH07
NOMESCO Finland
Cathetrisation of artery
9.0
197.6
474
752
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
190.0
178
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
7.8
184.8
491
902
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
179.1
168
*
WX408
NOMESCO Finland
General anesthesy, balanced
5.3
164.2
657
1989
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
156.2
147
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
1665.9
154.1
147
*
B01AB05
ATC
enoxaparin; parenteral
4.6
148.7
718
2578
L01XE04
ATC
[U] sunitinib; oral
+∞
147.5
139
*
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
33.3
133.1
176
60
1502
Kela drug reimbursment
Cabozantinib
+∞
130.3
123
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
355.0
128.7
128
*
WX402
NOMESCO Finland
General anaesthesia
5.7
126.5
423
985
3012
Kela drug reimbursment
Cabozantinib
+∞
124.9
118
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
1226.1
117.5
113
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
4.0
113.0
592
2144
H02AB02
ATC
dexamethasone; systemic
31.3
111.0
149
53
WZC30
NOMESCO Finland
Teaching
6.2
110.6
334
673
XX3DW
NOMESCO Finland
Time consuming IT work
9.0
105.8
239
313
A03FA01
ATC
metoclopramide; systemic, rectal
5.6
103.9
344
770
159
Kela drug reimbursment
Pazopanib
+∞
103.4
98
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.4
100.2
870
4582
Z51.5
ICD-10 Finland
Palliative care
17.3
95.2
154
99
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
12.8
89.4
165
145
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
110.5
86.1
93
9
A04AA02
ATC
granisetron; systemic, transdermal
879.6
85.5
83
*
N02BE01
ATC
paracetamol; systemic, rectal
5.4
82.1
1315
10210
L01XE26
ATC
[U] cabozantinib; oral
+∞
80.0
76
*
U75
ICPC
Malignant neoplasm of kidney
+∞
80.0
76
*
L01EX07
ATC
cabozantinib; oral
+∞
74.6
71
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
73.6
70
*
322
Kela drug reimbursment
Sunitinib
+∞
73.6
70
*
L01XE11
ATC
[U] pazopanib; oral
+∞
70.4
67
*
N02AA05
ATC
oxycodone; systemic
4.3
70.3
299
838
WF002
NOMESCO Finland
Radical radiotherapy
82.6
69.8
78
10
N02AX02
ATC
tramadol; systemic, rectal
2.7
69.6
767
4288
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
15.0
68.1
116
84
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
65.1
62
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
172.9
63.5
66
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
81.9
62.6
70
9
JN3AD
NOMESCO Finland
Abdominal CT examination
5.0
59.8
209
475
116
Kela drug reimbursment
Prostate cancer
+∞
58.7
56
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.2
57.5
367
1405
KAC00
NOMESCO Finland
Nephrectomy
108.0
57.3
62
6
TPH04
NOMESCO Finland
Cathetrisation of vein
3.0
57.1
409
1696
R4110
NOMESCO Finland
Physiotherapy
2.7
54.7
482
2264
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
8.2
54.7
127
168
ZXC96
NOMESCO Finland
Robot assisted procedure
39.6
54.0
68
18
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
134.8
49.1
52
*
KA1AE
NOMESCO Finland
Kidney ultrasound examination
9.8
48.7
101
110
S18
ICPC
Laceration/cut
2.3
48.2
702
4233
115
Kela drug reimbursment
Breast cancer
+∞
48.2
46
*
R31
ICD-10 Finland
Unspecified haematuria
3.6
47.2
237
747
158
Kela drug reimbursment
Everolimus
+∞
47.1
45
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
47.1
45
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
67.4
45.4
52
8
UKC02
NOMESCO Finland
Cystoscopy
2.9
45.1
327
1339
PJA12
NOMESCO Finland
Sentinel node biopsy
232.2
44.2
45
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
44.0
42
*
WX110
NOMESCO Finland
Local anesthesy
2.2
42.7
969
7005
168
Kela drug reimbursment
Axitinib
+∞
41.9
40
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.8
40.3
185
537
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
210.9
40.0
41
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
39.8
38
*
C64.80
ICD-10 Finland
Wilms tumour
+∞
39.8
38
*
KA3LT
NOMESCO Finland
Njurlesion coagulation
205.6
39.0
40
*
KAC01
NOMESCO Finland
Percutaneous endoscopic nephrectomy
205.6
39.0
40
*
WX704
NOMESCO Finland
Intubation
4.0
38.9
165
447
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
387.4
38.2
38
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
37.7
36
*
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
8.7
37.5
83
101
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.3
36.4
203
686
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
35.6
34
*
343
Kela drug reimbursment
Pazopanib
+∞
35.6
34
*
Y77
ICPC
Malignant neoplasm prostate
+∞
35.6
34
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
35.6
34
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
345.1
34.1
34
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
33.5
32
*
L01XE10
ATC
[U] everolimus; oral
+∞
33.5
32
*
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.7
33.0
153
446
KH1CD
NOMESCO Finland
Very extensive urinary tract ultrasound examination
15.0
32.9
55
38
D41.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Renal pelvis
174.0
32.8
34
*
L01EX01
ATC
sunitinib; oral
+∞
32.4
31
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
32.4
31
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
32.4
31
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
32.4
31
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
168.8
31.8
33
*
U14
ICPC
Kidney symptom/complaint
10.6
31.6
62
61
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.4
31.2
298
1396
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
30.3
29
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
308.7
29.9
30
*
C08CA01
ATC
amlodipine; oral
1.9
29.8
632
4167
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
51.2
29.5
35
7
L01XE17
ATC
[U] axitinib; oral
+∞
29.3
28
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.6
29.2
138
408
L02AE02
ATC
leuprorelin; implant, parenteral
41.0
29.1
36
9
I10
ICD-10 Finland
Essential (primary) hypertension
1.9
29.0
951
7312
ZX080
NOMESCO Finland
Image guided radiotherapy
297.8
28.9
29
*
GD1AD
NOMESCO Finland
Thorax CT examination
4.7
28.8
102
231
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.0
28.7
119
314
A04AA01
ATC
ondansetron; systemic, rectal
6.5
28.5
76
123
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.9
28.2
123
339
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.9
28.1
182
676
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
65.4
28.0
32
5
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
286.9
27.8
28
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
142.7
26.7
28
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
6.5
26.3
70
113
L02BB03
ATC
bicalutamide; oral
+∞
26.1
25
*
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
5.3
26.1
81
159
WX725
NOMESCO Finland
Noninvasive ventilation
4.2
26.0
104
265
SPAT1153
SPAT
Removal of sutures
1.9
26.0
503
3163
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
74.1
25.9
29
*
ZX120
NOMESCO Finland
Intravenous
3.2
25.8
145
489
L01BC06
ATC
capecitabine; oral
+∞
25.1
24
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
25.1
24
*
BCA30
NOMESCO Finland
Unilateral adrenalectomy
254.4
24.7
25
*
ZXA05
NOMESCO Finland
Left side
2.0
24.5
408
2415
WW500
NOMESCO Finland
Blood transfusion
6.1
24.4
68
117
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
10.3
24.4
48
48
N18.8
ICD-10 Finland
Other chronic renal failure
4.9
24.2
81
173
C50.99
ICD-10 Finland
Breast, unspecified
+∞
24.0
23
*
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
25.9
24.0
33
13
A79
ICPC
Malignancy NOS
68.6
23.9
27
*
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
8.6
23.5
51
61
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
+∞
23.0
22
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
122.0
22.6
24
*
R93.4
ICD-10 Finland
Abnormal findings on diagnostic imaging of urinary organs
24.3
22.2
31
13
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
21.9
21
*
HAC20
NOMESCO Finland
Total mastectomy
63.5
21.9
25
*
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.3
21.9
227
1091
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.7
21.8
164
663
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
3.8
21.0
91
250
340
Kela drug reimbursment
Everolimus
+∞
20.9
20
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
20.9
20
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
20.9
20
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
20.9
20
*
361
Kela drug reimbursment
Axitinib
+∞
20.9
20
*
XKD00
NOMESCO Finland
Uroflowmetry
2.1
20.9
266
1401
L02BG04
ATC
letrozole; oral
25.9
20.5
28
11
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
18.6
20.4
31
17
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
6.9
20.0
50
75
D30.0
ICD-10 Finland
Benign neoplasm: Kidney
12.8
19.9
35
28
198
Kela drug reimbursment
Sorafenib
+∞
19.8
19
*
C65
ICD-10 Finland
Malignant neoplasm of renal pelvis
+∞
19.8
19
*
C03CA01
ATC
furosemide; systemic
1.8
19.8
431
2765
L03AA13
ATC
pegfilgrastim; parenteral
202.7
19.6
20
*
PJD43
NOMESCO Finland
Excision of aortic lymph nodes
202.7
19.6
20
*
M05BX04
ATC
denosumab; parenteral
3.8
19.3
85
237
A02BC02
ATC
pantoprazole; systemic
1.7
19.2
885
7062
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
3.3
19.1
98
309
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
8.6
19.0
41
49
PHN71
NOMESCO Finland
Excision of tumor mass from inferior vena cava
+∞
18.8
18
*
PHE70
NOMESCO Finland
Thrombectomy of inferior vena cava
+∞
18.8
18
*
KA4AT
NOMESCO Finland
Cytology of kidney with ultrasound guidance
101.4
18.6
20
*
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
9.7
18.4
37
39
KCD02
NOMESCO Finland
Transurethral resection of bladder
16.4
18.4
29
18
ZXA00
NOMESCO Finland
Right side
1.8
18.3
407
2617
D44.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Adrenal gland
11.2
18.2
34
31
R50.9
ICD-10 Finland
Fever, unspecified
2.3
18.2
187
890
J01MA02
ATC
ciprofloxacin; systemic
1.7
18.2
532
3714
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
67.5
17.7
20
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
17.7
17
*
TK800
NOMESCO Finland
Hemodialysis
4.8
17.1
57
122
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.0
17.1
255
1421
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
3.3
16.8
87
277
J01DB01
ATC
cefalexin; oral
1.7
16.7
1090
9376
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
16.7
16
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
16.7
16
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
16.7
16
*
C79.7
ICD-10 Finland
Secondary malignant neoplasm of adrenal gland
+∞
16.7
16
*
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
+∞
16.7
16
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
16.7
16
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
171.9
16.5
17
*
R4190
NOMESCO Finland
Nutritional therapy
5.5
16.4
48
89
L03AA02
ATC
filgrastim; parenteral
40.6
16.3
20
5
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
40.6
16.3
20
5
AA1BD
NOMESCO Finland
Extensive CT of head and brain
5.0
16.1
52
108
KH1AD
NOMESCO Finland
CT of urinary organs
3.8
16.1
68
184
A04AA55
ATC
palonosetron, combinations; systemic
+∞
15.6
15
*
L01XE05
ATC
[U] sorafenib; oral
+∞
15.6
15
*
A06AH03
ATC
naloxegol; oral
22.3
15.6
22
10
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
161.7
15.5
16
*
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
3.4
15.5
75
227
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
14.6
14
*
L01EX03
ATC
pazopanib; oral
+∞
14.6
14
*
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
14.6
14
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
14.6
14
*
L02BA01
ATC
tamoxifen; oral
80.9
14.6
16
*
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
9.5
14.5
29
31
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
36.4
14.5
18
5
WX290
NOMESCO Finland
Other blockade of nerve
1.6
14.2
497
3577
J01MA12
ATC
levofloxacin; systemic
1.8
14.1
253
1498
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
8.1
14.1
31
39
V03AE01
ATC
polystyrene sulfonate; oral
6.7
14.1
35
53
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.2
13.8
141
667
L01EK01
ATC
axitinib; oral
+∞
13.6
13
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
13.6
13
*
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
+∞
13.6
13
*
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
13.6
13
*
Z85.5
ICD-10 Finland
Personal history of malignant neoplasm of urinary tract
+∞
13.6
13
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
141.3
13.5
14
*
BCA31
NOMESCO Finland
Endoscopic unilateral adrenalectomy
18.4
13.4
20
11
JN6AD
NOMESCO Finland
CT of torso and neck
13.9
13.2
22
16
WX306
NOMESCO Finland
Lumbar epidural anesthesy
3.4
13.2
64
195
WX600
NOMESCO Finland
Single shot through catheter
15.2
13.1
21
14
ZX050
NOMESCO Finland
Stereotactic radiotherapy
22.8
12.9
18
8
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.2
12.8
131
622
B01AB04
ATC
dalteparin; parenteral
2.9
12.7
79
287
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.6
12.6
385
2664
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
+∞
12.5
12
*
A04AD12
ATC
aprepitant; systemic
+∞
12.5
12
*
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
24.5
12.5
17
7
PC5DT
NOMESCO Finland
Embolisation of tumor of kidney
131.1
12.5
13
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
14.5
12.3
20
14
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
5.0
12.2
38
77
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.8
12.1
237
1438
D64.9
ICD-10 Finland
Anaemia, unspecified
2.1
12.1
145
735
TQW99
NOMESCO Finland
Other minor procedure on skin
3.2
12.1
62
198
A11CC03
ATC
alfacalcidol; systemic
3.9
12.0
49
130
A10BH05
ATC
linagliptin; oral
2.6
12.0
90
366
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
4.0
11.9
47
121
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
47.1
11.9
14
*
M84.4
ICD-10 Finland
Pathological fracture, not elsewhere classified
30.3
11.6
15
5
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
30.3
11.6
15
5
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.4
11.6
97
418
Z31.5
ICD-10 Finland
Genetic counselling
4.2
11.6
43
105
ZZR00
NOMESCO Finland
Flap of skin
10.1
11.5
22
22
M49.5*C79.5
ICD-10 Finland
Metastatic fracture of vertebra
+∞
11.5
11
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
11.5
11
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
11.5
11
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
11.5
11
*
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
+∞
11.5
11
*
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
120.9
11.4
12
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.2
11.4
112
522
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
17.2
11.2
17
10
RJ128
NOMESCO Finland
NA
25.2
11.1
15
6
E0000UV
ATC
NA
1.5
11.1
463
3429
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.3
11.0
107
496
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.0
10.9
151
812
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
43.7
10.9
13
*
WX892
NOMESCO Finland
Monitored bed care
2.1
10.9
121
594
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
12.0
10.8
19
16
N02AJ06
ATC
codeine and paracetamol; systemic
1.5
10.8
479
3589
N28.1
ICD-10 Finland
Cyst of kidney
4.3
10.8
39
93
TKC20
NOMESCO Finland
Catheterisation of bladder
2.2
10.7
106
493
U06
ICPC
Haematuria
3.6
10.7
47
134
Z90.5
ICD-10 Finland
Acquired absence of kidney
60.4
10.6
12
*
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
2.0
10.6
139
733
H02AB09
ATC
hydrocortisone; systemic
4.3
10.6
38
90
205
Kela drug reimbursment
Chronic hypertension
1.5
10.6
431
3167
G04CA02
ATC
tamsulosin; oral
1.5
10.6
380
2716
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
10.5
398
2876
M04AA01
ATC
allopurinol; systemic
1.8
10.5
205
1240
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
110.8
10.4
11
*
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
110.8
10.4
11
*
C50
ICD-10 Finland
Malignant neoplasm of breast
+∞
10.4
10
*
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
+∞
10.4
10
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
10.4
10
*
KBJ10
NOMESCO Finland
Cutaneous ureteroenterostomy
+∞
10.4
10
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
10.4
10
*
C44.81
ICD-10 Finland
Overall basocellular carcinoma of the skin
+∞
10.4
10
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
10.4
10
*
180
Kela drug reimbursment
Interferon alfa
+∞
10.4
10
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
+∞
10.4
10
*
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
+∞
10.4
10
*
AA1AD
NOMESCO Finland
CT of head and brain
1.6
10.4
352
2478
HA1AA
NOMESCO Finland
X-ray mammography
3.7
10.3
44
122
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
32.8
10.3
13
*
B03XA02
ATC
darbepoetin alfa; parenteral
4.6
10.2
34
75
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.8
9.9
62
226
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.7
9.9
66
250
KB1CG
NOMESCO Finland
Extensive MRI examination of urinary tract with high intensity magnet
100.7
9.4
10
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
9.4
9
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
9.4
9
*
D41
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of urinary organs
+∞
9.4
9
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
+∞
9.4
9
*
8130/2-C67.9
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder, NOS
+∞
9.4
9
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
9.4
9
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
9.4
9
*
C79.0
ICD-10 Finland
Secondary malignant neoplasm of kidney and renal pelvis
+∞
9.4
9
*
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
+∞
9.4
9
*
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
+∞
9.4
9
*
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.3
9.3
85
383
A06AD11
ATC
lactulose; oral
1.8
9.2
178
1074
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
3.5
9.2
42
124
H02AB06
ATC
prednisolone; systemic
1.4
9.2
586
4689
E87.5
ICD-10 Finland
Hyperkalaemia
4.5
9.2
31
70
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
4.0
9.2
35
89
JAD30
NOMESCO Finland
Repair of incisional hernia using prosthetic material
4.1
9.1
34
85
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
4.9
9.0
28
58
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
18.7
8.9
13
7
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
24.2
8.9
12
5
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
5.8
8.9
24
42
JMA10
NOMESCO Finland
Transabdominal total splenectomy
14.1
8.7
14
10
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
50.3
8.7
10
*
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
3.1
8.5
44
144
N03AX16
ATC
pregabalin; oral
1.5
8.5
292
2052
GD1AT
NOMESCO Finland
Biopsy of the lung with ultrasound guidance
90.6
8.4
9
*
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
90.6
8.4
9
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
90.6
8.4
9
*
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
+∞
8.3
8
*
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
+∞
8.3
8
*
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
8.3
8
*
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
+∞
8.3
8
*
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
8.3
8
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
8.3
8
*
NK6BQ
NOMESCO Finland
Whole body extensive bone SPET with low dose CT
+∞
8.3
8
*
L02BX02
ATC
degarelix; parenteral
+∞
8.3
8
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
8.3
8
*
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
+∞
8.3
8
*
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
+∞
8.3
8
*
8090/3-C44.4
ICD-O-3
Basal cell carcinoma, NOS, of skin of scalp and neck
+∞
8.3
8
*
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
+∞
8.3
8
*
8140/3-C18.0
ICD-O-3
Adenocarcinoma, NOS, of cecum
+∞
8.3
8
*
WF090
NOMESCO Finland
Profylactic radiotherapy
+∞
8.3
8
*
WX002
NOMESCO Finland
Sedation and analgesia
1.5
8.2
269
1864
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.7
8.1
160
970
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.5
8.1
362
2687
ZX100
NOMESCO Finland
Oral
5.1
8.0
24
48
KH1BD
NOMESCO Finland
Extensive urinary tract CT examination
6.3
8.0
20
32
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.0
8.0
94
476
WX882
NOMESCO Finland
High dependency care
3.1
8.0
41
134
XW000
NOMESCO Finland
Bone marrow biopsy
2.9
7.9
47
168
SPAT1254
SPAT
Administration of medicine
1.7
7.9
188
1200
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
13.1
7.9
13
10
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.0
7.8
95
484
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.8
7.8
48
176
XF600
NOMESCO Finland
Bloodpressure measurement
2.1
7.8
88
438
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.5
7.7
285
2030
TGD00
NOMESCO Finland
Needle biopsy of lung
15.1
7.7
12
8
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
45.2
7.7
9
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
45.2
7.7
9
*
J94.8
ICD-10 Finland
Other specified pleural conditions
4.4
7.6
26
60
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
18.5
7.6
11
6
OAB42
NOMESCO Finland
Guidance related to known health problem
25.1
7.6
10
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
5.4
7.5
21
39
L57.0
ICD-10 Finland
Actinic keratosis
1.9
7.5
103
554
D41.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Urinary organ, unspecified
80.5
7.4
8
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.3
7.4
69
315
JAH01
NOMESCO Finland
Laparoscopy
3.0
7.4
40
136
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
13.4
7.4
12
9
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
5.6
7.4
20
36
JFB30
NOMESCO Finland
Right hemicolectomy
8.4
7.3
15
18
UJF32
NOMESCO Finland
Coloscopy
1.5
7.3
309
2264
C78.1
ICD-10 Finland
Secondary malignant neoplasm of mediastinum
+∞
7.3
7
*
8500/3-C50.2
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast
+∞
7.3
7
*
X76
ICPC
Malignant neoplasm breast female
+∞
7.3
7
*
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
+∞
7.3
7
*
C18.20
ICD-10 Finland
Malignant tumor of the ascending colon without histology
+∞
7.3
7
*
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
+∞
7.3
7
*
1XC17
NOMESCO Finland
NA
+∞
7.3
7
*
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
+∞
7.3
7
*
C83.00
ICD-10 Finland
Lymphocytic lymphoma
+∞
7.3
7
*
L01EG02
ATC
everolimus; oral (mammalian target of rapamycin kinase inhibitors (mtor))
+∞
7.3
7
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
7.3
7
*
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
+∞
7.3
7
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
7.3
7
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
7.3
7
*
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
+∞
7.3
7
*
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
+∞
7.3
7
*
PHN70
NOMESCO Finland
Plastic repair of inferior vena cava
+∞
7.3
7
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
7.3
7
*
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
+∞
7.3
7
*
M907, C6488
ICD-10 Finland
NA
+∞
7.3
7
*
WW200
SPAT
NA
0.4
7.3
39
853
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.8
7.2
46
170
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
3.6
7.2
30
84
E89.6
ICD-10 Finland
Postprocedural adrenocortical(-medullary) hypofunction
30.2
7.1
9
*
GDB10
NOMESCO Finland
Wedge resection of lung
20.1
7.1
10
5
ZXK00
NOMESCO Finland
Conversion from percutaneous endoscopic to open procedure
8.0
7.1
15
19
TKE00
NOMESCO Finland
Needle biopsy of prostate
3.0
7.1
38
129
SPAT1263
SPAT
Sampling
1.4
7.1
510
4117
PG1PT
NOMESCO Finland
Extensive endovascular embolisation for bleeding with radiological guidance not elsewhere classified
8.8
7.0
14
16
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
5.9
6.9
18
31
ZX112
NOMESCO Finland
Subcutaneous
5.9
6.9
18
31
N18.0
ICD-10 Finland
End-stage renal disease
4.1
6.9
25
62
105
Kela drug reimbursment
Adrenal cortical hypofunction
13.8
6.9
11
8
JAD11
NOMESCO Finland
Laparoscopic repair of incisional hernia
4.4
6.8
23
53
Z49.0
ICD-10 Finland
Preparatory care for dialysis
4.4
6.8
23
53
N05CF01
ATC
zopiclone; oral
1.4
6.8
385
2977
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
6.8
569
4699
R84
ICPC
Malignant neoplasm bronchus/lung
40.2
6.8
8
*
H03AA01
ATC
levothyroxine sodium; systemic
1.5
6.8
251
1788
KWD00
NOMESCO Finland
Reoperation for superficial haemorrhage in urological surgery
16.8
6.7
10
6
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
4.1
6.7
24
59
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
3.6
6.7
28
79
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
2.4
6.7
56
243
N99.0
ICD-10 Finland
Postprocedural renal failure
22.6
6.7
9
*
XJH00
NOMESCO Finland
Transanal ultrasonography
2.0
6.6
80
412
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
12.3
6.6
11
9
KDE20
NOMESCO Finland
Removal of foreign body from urethra
8.7
6.6
13
15
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.6
6.5
159
1022
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.9
6.5
38
135
KCD32
NOMESCO Finland
Cystoscopic destruction of tumour of bladder
10.1
6.5
12
12
C08CA02
ATC
felodipine; oral
1.7
6.5
133
815
C90.0
ICD-10 Finland
Multiple myeloma
70.1
6.4
7
*
U79
ICPC
Neoplasm urinary tract unspecified
70.1
6.4
7
*
GEA20
NOMESCO Finland
Mediastinoscopy with excision of lesion
70.1
6.4
7
*
KC1GB
NOMESCO Finland
Cystography with X-ray
14.4
6.4
10
7
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
14.4
6.4
10
7
SPAT1262
SPAT
Handing over of treatment supplies
1.5
6.4
249
1788
J01CA04
ATC
amoxicillin; systemic
1.4
6.4
973
8776
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
5.2
6.3
18
35
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.6
6.3
149
953
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
3.6
6.3
26
73
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
3.7
6.3
25
68
L02AE04
ATC
triptorelin; parenteral
+∞
6.3
6
*
C16.9
ICD-10 Finland
Malignant neoplasm: Stomach, unspecified
+∞
6.3
6
*
8140/3-C34.3
ICD-O-3
Adenocarcinoma, NOS, of lower lobe, lung
+∞
6.3
6
*
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
+∞
6.3
6
*
ZX022
NOMESCO Finland
LDR radiotherapy within tissue
+∞
6.3
6
*
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
+∞
6.3
6
*
C15.5
ICD-10 Finland
Malignant neoplasm: Lower third of oesophagus
+∞
6.3
6
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
6.3
6
*
8170/3-C22.0
ICD-O-3
Hepatocellular carcinoma, NOS, of liver
+∞
6.3
6
*
8140/3-C34.1
ICD-O-3
Adenocarcinoma, NOS, of upper lobe, lung
+∞
6.3
6
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
6.3
6
*
C18.21
ICD-10 Finland
Malignant tumor of the ascending colon invasive carcinoma
+∞
6.3
6
*
Z93.3
ICD-10 Finland
Colostomy status
12.6
6.1
10
8
K43.2
ICD-10 Finland
Incisional hernia without obstruction or gangrene
12.6
6.1
10
8
C02AC05
ATC
moxonidine; oral
2.0
6.1
72
369
C09CA01
ATC
losartan; oral
1.4
6.1
329
2517
N18.5
ICD-10 Finland
Chronic kidney disease, stage 5
8.6
6.1
12
14
GD5CD
NOMESCO Finland
Thorax and upper abdomen combined very extensive CT examination of
6.7
6.0
14
21
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
10.1
6.0
11
11
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.7
6.0
124
763
A10AE04
ATC
insulin glargine; parenteral
1.7
6.0
129
805
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
1163
5404
5.62
209.78
5.1
3.7
—
—
—
0
0
1100
5354
4.64
173.86
8.3
3.8
34.5
35.5
g/l
7.24
1047
4931
486
1310
4.95
171.34
4.5
2.8
224.4
235.8
u/l
1.49
476
1221
351
722
5.99
168.76
7.1
10.4
—
—
—
0
0
1163
6159
4.56
156.87
12.9
3.9
10.8
12.4
umol/l
4.62
1127
5764
1112
5815
4.23
149.87
9.3
5.3
1.2
1.2
mmol/l
1.35
1054
5141
450
1315
4.41
140.25
7.0
8.0
120.5
122.8
g/l
1.52
439
1269
472
1434
4.30
139.55
6.8
7.6
96.8
95.2
%
8.59
457
1382
1331
8171
5.47
137.65
5.9
4.3
914.1
2113.5
e6/l
0.52
14
117
839
3788
3.65
137.61
4.8
3.1
78.3
93.0
e6/l
0.20
718
2911
494
1572
4.15
136.73
6.7
7.3
-0.1
1.2
mmol/l
10.62
398
1224
492
1578
4.10
134.42
6.8
7.3
5.3
5.1
kpa
5.53
476
1513
491
1578
4.09
133.68
6.7
7.3
13.9
11.6
kpa
14.25
475
1514
1139
6388
3.96
130.50
10.9
5.8
1.2
1.2
mmol/l
2.33
949
5400
1440
9681
7.93
126.38
15.8
5.5
81.9
76.9
u/l
4.63
1418
8948
775
3474
3.46
125.64
4.5
3.0
0.4
0.5
e6/l
0.10
653
2612
405
1194
4.24
123.24
7.8
6.7
11.0
10.7
mmol/l
0.44
386
1130
1253
7753
4.22
117.90
7.2
4.6
6.9
6.9
mmol/l
0.08
1217
7260
478
1646
3.75
115.77
8.4
6.4
104.7
104.3
mmol/l
1.39
469
1599
1012
5527
3.40
114.87
10.9
10.4
1.2
1.3
inr
5.52
301
1544
646
2747
3.32
111.29
2.7
2.2
—
—
—
0
0
283
686
4.82
110.11
7.8
9.5
23.5
24.4
mmol/l
4.24
274
636
621
2630
3.27
106.91
3.4
2.4
4.0
4.7
e6/l
1.08
561
2290
1127
6758
3.45
105.54
15.1
6.3
4.3
4.4
e9/l
0.60
997
5832
498
1880
3.43
103.06
4.5
2.6
0.8
0.8
mmol/l
1.42
476
1730
786
3942
3.02
98.73
7.5
2.1
2.4
2.4
mmol/l
0.89
725
3263
270
702
4.45
95.48
3.2
1.4
9.8
4.3
ug/l
0.42
218
532
445
1672
3.33
91.44
7.9
5.3
1.1
1.0
mmol/l
2.13
423
1541
767
3947
2.87
89.41
4.7
2.3
67.5
59.1
u/l
1.06
728
3602
488
1971
3.15
88.40
4.2
2.8
2.0
2.0
e6/l
0.06
319
1074
289
846
3.97
86.57
8.4
8.9
95.4
93.5
%
11.26
289
841
288
845
3.96
85.96
8.2
8.9
0.5
0.7
%
15.97
288
838
289
854
3.93
85.35
8.1
8.8
0.9
1.4
%
11.46
289
848
341
1154
3.51
82.02
7.4
6.8
1.2
1.4
mmol/l
5.93
333
1115
490
2160
2.86
73.92
4.0
2.6
0.8
1.3
e6/l
1.53
319
1259
484
2259
2.66
63.92
6.9
2.1
2.5
2.4
mmol/l
5.52
455
1944
689
3819
2.45
62.88
5.1
2.7
31.0
41.3
u/l
1.41
660
3606
452
2083
2.65
60.81
2.2
1.8
29.9
30.0
s
0.15
447
2014
286
1033
3.17
60.52
5.9
1.8
384.8
362.3
nmol/l
1.10
277
928
125
255
5.24
58.54
3.0
1.9
1356.1
59.5
u/ml
0.51
110
202
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
160
411
4.23
56.42
3.0
2.8
0.4
0.3
u/ml
0.52
72
245
382
1707
2.64
53.91
3.3
2.6
20.5
23.2
%
3.06
323
1441
421
1994
2.53
52.48
3.2
2.4
11.0
13.1
umol/l
6.72
397
1838
395
1842
2.54
50.67
3.2
2.5
2.1
2.3
g/l
8.25
375
1708
128
321
4.26
46.42
5.5
8.0
105.8
105.4
mmol/l
0.63
118
290
84
148
5.94
45.98
1.3
1.2
—
—
—
0
0
291
1240
2.66
44.42
3.1
2.3
7.4
8.6
umol/l
0.49
263
1081
294
1321
2.51
39.90
4.1
3.1
—
—
—
0
0
240
977
2.72
39.83
1.9
2.0
0.2
0.2
g/l
0.93
228
884
404
2131
2.21
37.67
1.9
1.8
—
—
—
0
0
1467
12667
3.99
37.17
27.5
13.3
35.4
24.6
mg/l
23.08
1399
9906
166
602
2.97
33.99
5.3
5.4
1.8
1.7
%
1.18
155
571
873
6229
1.92
33.84
4.8
3.6
0.0
0.0
estimate
0.00
218
1068
1205
9608
2.14
33.82
4.8
4.1
18.7
12.1
mm/h
20.43
1121
8840
245
1099
2.46
32.94
3.1
1.6
65.9
66.8
g/l
1.00
226
998
66
129
5.30
32.29
1.5
1.2
30.8
29.9
iu/l
0.06
47
109
84
201
4.36
32.28
1.5
1.4
15.3
7.0
u/l
3.74
68
167
215
916
2.56
32.21
6.3
7.1
24.2
24.5
mmol/l
0.75
203
855
228
1001
2.50
32.06
6.6
2.9
1.2
1.2
mmol/l
0.53
211
836
873
6311
1.88
31.62
4.8
3.6
0.0
0.0
estimate
0.36
218
1031
199
834
2.59
30.79
1.8
1.6
—
—
—
0
0
227
1013
2.45
30.75
5.6
3.8
129.7
95.6
ng/l
3.51
202
863
306
1570
2.18
29.83
2.5
2.1
1.8
1.8
%
0.12
280
1372
264
1285
2.27
29.24
5.8
3.3
1.5
2.1
mmol/l
1.34
219
1045
853
6236
1.82
28.62
6.7
4.8
0.0
0.0
estimate
0.00
227
1082
263
1296
2.24
28.21
5.8
3.3
6.0
5.9
kpa
1.13
257
1251
224
1031
2.37
28.20
3.3
2.2
37.2
40.6
u/l
0.25
201
867
160
629
2.72
28.05
6.1
3.8
23.8
24.4
mmol/l
1.32
152
552
504
3221
1.84
25.66
2.3
2.2
3.2
2.9
mg/l
1.34
434
2714
69
170
4.20
25.52
1.4
1.2
0.2
0.4
nmol/l
—
7
15
24
19
12.81
24.63
11.7
1.1
52.8
41.3
u/l
—
14
6
275
1496
2.02
22.43
1.8
1.8
—
—
—
0
0
276
1504
2.02
22.40
1.8
1.7
—
—
—
0
0
147
620
2.51
22.24
1.6
1.5
1.8
1.5
g/l
2.35
124
532
58
141
4.23
21.84
1.4
1.5
1294.3
1613.6
e6/l
0.42
39
101
673
4844
1.69
21.67
3.4
2.7
215.3
151.0
ug/l
4.30
606
4400
732
5388
1.68
21.64
4.6
3.8
40.8
61.4
ng/l
1.14
595
4006
1489
13610
3.43
21.61
35.9
16.3
139.0
139.8
mmol/l
28.77
1484
13249
1490
13653
3.40
20.95
36.2
16.4
4.1
4.0
mmol/l
24.96
1484
13269
177
836
2.26
20.73
4.7
3.2
1.4
2.0
mmol/l
1.07
124
604
91
311
3.05
20.57
2.6
2.5
1.9
1.6
mg/l
2.35
82
276
66
185
3.68
20.43
3.2
5.5
1362.3
370.9
iu/ml
—
8
23
77
243
3.28
19.88
1.3
1.5
—
—
—
0
0
75
234
3.32
19.72
1.4
1.9
2.1
4.4
iu/l
2.82
18
82
19
15
12.81
19.45
2.1
3.1
—
—
—
0
0
130
551
2.48
19.43
4.9
3.1
4.3
4.5
pmol/l
0.96
120
468
125
521
2.52
19.35
1.9
1.8
1.0
1.5
ug/l
0.81
113
458
1205
10273
1.78
19.26
37.8
16.2
14.3
13.7
%
29.79
1198
10005
181
889
2.17
19.21
4.7
3.3
5.1
5.2
kpa
0.48
168
816
520
3635
1.65
17.86
3.2
2.5
2327.1
6618.4
umol/l
1.94
450
3114
50
127
4.03
17.79
1.3
1.5
34208.6
80504.3
e6/l
0.45
25
76
649
4817
1.60
17.30
5.4
3.8
—
—
—
0
0
1120
9502
1.65
16.58
7.4
3.6
15.1
15.0
pmol/l
1.27
1022
8520
80
288
2.87
16.50
3.1
2.3
16.6
16.7
%
0.04
49
156
28
46
6.18
16.42
1.9
2.3
15.2
14.4
%
—
6
22
27
43
6.37
16.31
2.0
2.4
—
—
—
0
0
83
307
2.80
16.29
3.0
2.8
8.0
8.0
kpa
0.02
78
282
52
146
3.65
16.09
2.5
2.0
19.7
91.3
u/ml
0.81
46
133
34
70
4.94
15.72
1.2
1.3
10.3
10.2
u/l
0.02
29
63
959
7894
1.56
15.61
3.7
3.0
67.7
51.4
u/l
4.15
884
7201
160
828
2.04
14.71
1.9
1.6
—
—
—
0
0
1309
11704
1.76
14.46
8.0
4.4
2.2
2.1
mu/l
0.36
1212
10548
391
2659
1.63
14.45
1.7
1.6
1.8
1.3
mg/l
1.50
329
2050
635
4829
1.53
14.44
3.4
3.2
7.3
7.6
mmol/l
1.35
518
4045
48
141
3.48
13.91
1.0
1.1
—
—
—
0
0
406
2814
1.60
13.79
5.0
4.0
2447.2
516.2
ng/l
0.44
351
2365
190
1074
1.88
13.48
4.1
2.7
4.6
4.5
kpa
0.31
182
1033
1259
11198
1.66
13.45
32.0
14.9
38.1
40.0
%
7.47
799
7304
86
357
2.49
13.44
1.9
1.8
—
—
—
0
0
644
4976
1.50
13.25
4.2
4.1
24.2
7.6
mg/mmol
5.52
409
3182
96
426
2.34
12.96
2.2
2.9
—
—
—
0
0
59
206
2.94
12.90
3.9
3.1
59.6
58.8
%
0.18
59
206
58
201
2.96
12.85
3.8
3.0
4.5
4.4
e9/l
0.11
58
201
1342
12193
1.75
12.61
32.5
12.4
62.2
76.4
ml/min/173m2
92.77
1240
9834
23
41
5.68
12.44
2.4
1.4
—
—
—
0
0
470
3439
1.53
12.33
5.2
3.9
0.0
0.0
estimate
0.14
204
1035
1469
13771
2.29
12.23
18.6
9.4
27.5
26.9
u/l
0.27
1441
13173
86
377
2.36
11.95
3.5
3.0
23.8
25.3
mmol/l
2.37
79
330
69
279
2.54
11.42
1.3
1.4
—
—
—
0
0
81
354
2.36
11.34
1.3
1.2
—
—
—
0
0
90
415
2.24
11.13
2.2
1.5
55.4
48.5
mg/l
0.38
68
332
574
4450
1.46
11.05
3.1
3.0
1914.6
1496.5
ng/l
1.06
515
3819
25
54
4.69
10.96
1.3
1.2
—
—
—
0
0
89
413
2.23
10.85
2.2
1.5
117.5
48.1
mg/l
0.56
66
330
1493
14179
2.47
10.53
44.4
19.6
245.0
240.6
e9/l
1.66
1481
13744
1493
14183
2.46
10.45
44.2
19.6
4.4
4.5
e12/l
24.27
1476
13687
1493
14184
2.45
10.43
44.3
19.6
7.2
6.8
e9/l
11.65
1477
13693
448
3370
1.46
9.86
1.6
1.5
18.7
20.3
nmol/l
1.49
389
2811
59
238
2.54
9.85
1.2
1.5
—
—
—
0
0
136
777
1.82
9.28
1.6
1.5
—
—
—
0
0
13
17
7.70
9.28
1.2
1.1
—
—
—
0
0
559
4426
1.41
9.16
2.1
2.2
256.5
233.8
u/l
0.18
525
4144
708
5836
1.39
9.16
2.1
2.0
92.3
93.2
pmol/l
0.18
408
3006
16
27
5.98
9.13
1.5
1.4
27.5
29.8
%
0.09
16
20
46
171
2.74
9.04
1.1
1.5
—
—
—
0
0
58
245
2.42
8.81
1.2
1.4
—
—
—
0
0
14
22
6.41
8.53
1.2
1.2
—
—
—
0
0
617
5023
1.38
8.38
2.5
2.2
79.2
77.9
nmol/l
0.47
561
4378
68
315
2.21
8.37
3.0
2.0
131.7
133.5
g/l
0.21
59
236
93
488
1.96
8.25
2.1
1.6
—
—
—
0
0
41
155
2.69
7.84
1.3
1.5
230.0
302.4
pmol/l
0.97
33
114
70
338
2.12
7.79
1.3
1.5
239.2
293.0
ug/g
1.43
46
203
97
527
1.90
7.78
2.1
1.7
—
—
—
0
0
28
86
3.30
7.67
1.1
1.4
—
—
—
0
0
764
6511
1.34
7.43
2.6
2.3
—
—
—
0
0
107
609
1.81
7.42
1.3
1.2
182.0
135.3
iu/ml
0.38
33
236
32
109
2.98
7.41
2.2
2.2
—
—
—
0
0
98
543
1.86
7.41
1.6
1.4
8.2
7.5
g/l
1.74
66
411
98
543
1.86
7.41
1.5
1.4
4.1
3.9
g/l
0.69
63
401
98
543
1.86
7.41
1.5
1.4
—
—
—
0
0
33
115
2.91
7.35
1.1
1.6
—
—
—
0
0
10
5
20.12
7.13
4.6
5.4
149.9
278.2
u/l
—
10
5
46
194
2.41
7.07
1.3
1.4
—
—
—
0
0
61
291
2.14
7.03
1.8
2.7
27.8
37.2
umol/l
1.59
44
249
25
76
3.33
6.98
1.6
2.1
—
—
—
0
0
92
511
1.85
6.91
1.5
1.4
10.9
10.4
g/l
0.39
72
433
38
152
2.54
6.55
1.2
1.4
—
—
—
0
0
13
25
5.24
6.49
1.2
1.2
317.7
53.7
ug/l
—
6
8
41
172
2.42
6.40
1.3
1.3
—
—
—
0
0
26
87
3.02
6.24
1.2
1.1
—
—
—
0
0
89
507
1.80
6.19
1.6
1.4
3.4
3.1
g/l
1.93
65
406
37
152
2.47
6.05
1.3
1.3
—
—
—
0
0
10
16
6.28
5.96
1.0
1.3
—
—
—
0
0
20
60
3.36
5.73
1.3
1.4
—
—
—
0
0
20
60
3.36
5.73
1.3
1.4
—
—
—
0
0
352
2762
1.36
5.62
1.8
1.7
1087.0
1168.4
nmol/l
0.96
287
2069
22
73
3.04
5.38
1.2
1.3
—
—
—
0
0
104
664
1.61
4.82
3.3
2.3
1.2
1.2
%
0.29
104
658
38
178
2.16
4.68
1.9
1.4
113.2
107.4
u/ml
0.20
13
28
77
459
1.71
4.65
1.8
1.4
1.1
0.4
g/l
0.68
65
398
72
424
1.73
4.55
2.4
2.2
178.2
88.1
ug/min
0.70
41
262
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
18
59
3.07
4.52
1.2
1.1
—
—
—
0
0
34
155
2.22
4.48
1.2
1.4
—
—
—
0
0
183
1338
1.42
4.45
2.9
3.0
282.4
208.6
ng/l
0.78
172
1239
22
82
2.71
4.42
1.6
1.6
—
—
—
0
0
31
139
2.26
4.26
1.9
2.3
717.8
653.6
ml
0.38
22
89
19
67
2.86
4.23
1.7
1.5
2.7
8.0
u/l
0.94
13
29
18
62
2.93
4.17
1.1
1.1
—
—
—
0
0
135
1887
0.69
4.16
9.9
6.6
—
—
—
0
0
27
116
2.35
4.10
1.4
1.3
—
—
—
0
0
68
412
1.68
3.92
1.4
1.4
0.0
0.0
g/l
0.59
62
379
71
439
1.65
3.80
1.5
1.3
36.6
37.8
g/l
0.81
61
375
26
114
2.30
3.79
1.2
1.3
—
—
—
0
0
253
2002
1.32
3.73
22.9
28.4
1.5
1.4
inr
0.26
37
284
64
390
1.67
3.63
1.4
1.3
0.0
0.0
g/l
0.00
59
358
24
104
2.33
3.60
1.2
1.2
51.4
49.7
u/l
0.07
16
74
137
990
1.42
3.58
2.0
2.2
11.8
14.9
nmol/l
4.56
120
858
713
6388
1.22
3.53
5.1
3.8
2.6
2.6
ug/l
0.00
631
5763
35
179
1.98
3.50
1.2
1.2
—
—
—
0
0
23
102
2.27
3.30
1.2
1.3
—
—
—
0
0
46
268
1.74
3.11
1.3
1.4
—
—
—
0
0
46
268
1.74
3.11
1.3
1.4
—
—
—
0
0
46
270
1.73
3.03
1.7
1.3
—
—
—
0
0
44
259
1.72
2.89
1.5
1.7
—
—
—
0
0
15
58
2.60
2.87
2.1
1.7
222.4
206.2
u/l
0.35
15
58
43
260
1.67
2.59
1.3
1.2
—
—
—
0
0
38
222
1.73
2.59
1.3
1.2
—
—
—
0
0
11
39
2.83
2.47
1.0
1.2
—
—
—
0
0
11
39
2.83
2.47
1.0
1.2
—
—
—
0
0
11
39
2.83
2.47
1.0
1.2
—
—
—
0
0
11
39
2.83
2.47
1.0
1.2
—
—
—
0
0
23
117
1.98
2.41
1.9
1.2
—
—
—
0
0
8
22
3.65
2.36
1.0
1.2
2.5
2.0
umol/l
—
8
22
31
177
1.77
2.31
1.3
1.2
225.1
265.4
u/ml
0.46
19
108
9
28
3.23
2.31
1.0
1.2
—
—
—
0
0
9
28
3.23
2.31
1.0
1.2
—
—
—
0
0
9
28
3.23
2.31
1.0
1.2
—
—
—
0
0
10
35
2.87
2.30
1.2
1.1
—
—
—
0
0
29
163
1.79
2.28
4.2
5.1
7.0
7.5
mmol/l
0.40
22
132
33
193
1.73
2.27
1.3
1.2
—
—
—
0
0
157
1249
1.29
2.26
2.9
2.2
359.2
170.0
ug/g
0.71
124
986
10
36
2.79
2.20
1.2
1.1
—
—
—
0
0
333
2890
1.19
2.14
5.4
4.0
1.0
1.0
kg/l
0.13
66
416
12
49
2.46
2.10
1.1
1.1
—
—
—
0
0
10
37
2.71
2.10
3.5
2.0
—
—
—
0
0
29
168
1.74
2.08
2.0
2.5
16.5
21.1
mg/l
—
10
37
60
850
0.69
2.07
1.9
1.9
—
—
—
0
0
139
1102
1.29
2.07
4.5
2.3
48.5
63.1
ml/min/173m2
7.80
83
435
22
118
1.88
2.02
1.1
1.1
—
—
—
0
0
17
83
2.06
2.01
1.2
1.2
—
—
—
0
0
17
83
2.06
2.01
1.2
1.2
—
—
—
0
0
17
83
2.06
2.01
1.2
1.2
—
—
—
0
0
14
63
2.23
2.01
1.4
1.3
—
—
—
0
0
14
63
2.23
2.01
1.4
1.4
—
—
—
0
0
8
27
2.97
1.93
2.1
2.1
1.2
1.2
mmol/l
—
8
27
14
65
2.16
1.88
2.6
2.3
—
—
—
0
0
25
144
1.75
1.85
1.3
1.2
—
—
—
0
0
14
67
2.10
1.76
1.1
1.0
—
—
—
0
0
415
3725
1.16
1.75
1.7
1.7
1.6
1.4
mmol/l
4.85
342
3071
65
476
1.38
1.70
1.4
1.6
112.0
318.5
titre
—
5
26
14
68
2.07
1.70
2.2
1.5
2.9
5.0
u/field
0.33
14
50
20
111
1.81
1.69
1.1
1.1
—
—
—
0
0
24
141
1.71
1.68
1.2
1.2
—
—
—
0
0
12
55
2.19
1.67
1.2
1.3
—
—
—
0
0
12
55
2.19
1.67
1.2
1.3
—
—
—
0
0
6
19
3.17
1.66
1.2
1.2
—
—
—
0
0
6
19
3.17
1.66
4.3
4.2
—
—
—
0
0
5
14
3.58
1.61
1.0
1.6
—
—
—
0
0
24
143
1.69
1.61
1.3
1.2
—
—
—
0
0
272
2387
1.17
1.54
1.2
1.2
2.5
1.9
u/ml
0.15
60
629
8
33
2.43
1.54
1.1
1.1
—
—
—
0
0
10
44
2.28
1.53
1.2
1.3
—
—
—
0
0
10
44
2.28
1.53
1.2
1.3
—
—
—
0
0
5
15
3.34
1.52
1.2
1.0
—
—
—
0
0
5
15
3.34
1.52
2.0
2.3
0.0
0.6
u/field
—
5
15
60
443
1.37
1.52
5.1
4.1
4.0
3.9
mmol/l
0.29
55
417
6
21
2.86
1.50
1.3
1.7
—
—
—
0
0
1332
12993
1.18
1.48
5.8
5.0
6.2
6.1
mmol/l
2.48
1195
11730
9
37
2.44
1.48
2.3
2.9
—
—
—
0
0
9
37
2.44
1.48
2.3
2.9
—
—
—
0
0
45
318
1.43
1.47
1.7
1.5
—
—
—
0
0
9
38
2.38
1.45
2.2
1.2
14.0
9.1
ug/l
—
9
38
9
38
2.38
1.45
1.1
1.1
—
—
—
0
0
9
38
2.38
1.45
1.1
1.1
—
—
—
0
0
47
336
1.41
1.45
1.1
1.1
—
—
—
0
0
46
333
1.39
1.34
1.1
1.1
—
—
—
0
0
12
221
0.54
1.33
1.2
1.3
—
—
—
0
0
12
61
1.97
1.33
1.4
1.3
—
—
—
0
0
22
137
1.61
1.29
1.3
1.2
—
—
—
0
0
8
34
2.36
1.29
1.1
2.4
—
6627.8
—
0
5
5
18
2.78
1.28
1.2
1.2
—
—
—
0
0
22
138
1.60
1.26
1.3
1.2
—
—
—
0
0
40
286
1.41
1.26
1.1
1.2
—
408.6
—
0
7
22
139
1.59
1.23
1.3
1.2
—
—
—
0
0
12
63
1.91
1.23
1.4
1.5
517.6
873.2
e6/l
—
5
26
337
3058
1.13
1.20
1.7
1.7
46350757.9
43642617.8
pmol/l
0.02
274
2493
158
1357
1.18
1.19
1.3
1.3
—
—
—
0
0
44
324
1.37
1.18
1.4
2.0
11.6
12.1
mg/l
0.16
39
295
5
20
2.50
1.15
1.0
1.6
—
—
—
0
0
18
111
1.63
1.12
1.8
2.0
5.2
1.9
u/field
—
10
42
7
31
2.26
1.10
1.1
1.1
—
—
—
0
0
22
144
1.54
1.09
3.3
4.0
—
—
—
0
0
12
67
1.80
1.04
1.1
1.3
504.8
413.6
u/l
0.08
12
62
42
316
1.34
1.02
2.1
1.7
—
—
—
0
0
15
91
1.65
1.00
1.3
1.2
2.7
2.0
mmol/l
0.78
15
85
12
69
1.74
0.96
1.2
1.1
—
—
—
0
0
12
69
1.74
0.96
1.3
1.1
—
—
—
0
0
6
28
2.15
0.91
2.2
1.6
252.0
148.1
ng/l
—
6
28
388
3605
1.10
0.91
3.1
2.7
0.9
0.7
ug/l
3.00
293
2427
40
306
1.32
0.89
5.8
2.9
6.9
7.5
mmol/l
0.93
40
292
1282
12571
1.11
0.89
6.9
6.5
41.4
40.8
mmol/mol
1.31
1187
11581
31
413
0.75
0.86
1.3
1.8
41.9
41.9
nmol/l
0.00
31
391
11
64
1.72
0.86
1.4
1.0
1.0
1.1
u/l
—
6
31
11
64
1.72
0.86
1.1
1.1
—
—
—
0
0
54
433
1.26
0.85
1.6
1.4
—
—
—
0
0
65
533
1.23
0.85
1.4
1.9
37.8
39.1
u/l
0.21
54
448
10
57
1.76
0.83
21.2
14.1
1615.2
1337.2
nmol/l
—
10
57
118
1034
1.15
0.76
1.3
1.4
—
—
—
0
0
9
53
1.70
0.75
1.1
1.1
—
—
—
0
0
541
5147
1.08
0.73
4.3
3.7
22.9
24.0
%
0.90
285
2459
46
371
1.25
0.72
1.7
1.6
0.7
7.9
iu/ml
—
5
79
7
40
1.75
0.71
1.4
1.1
—
—
—
0
0
5
26
1.93
0.70
1.4
1.2
—
—
—
0
0
11
69
1.60
0.68
1.3
1.2
—
—
—
0
0
5
28
1.79
0.66
1.0
1.1
—
—
—
0
0
8
51
1.57
0.60
1.4
1.3
—
—
—
0
0
8
52
1.54
0.59
1.1
1.0
—
—
—
0
0
40
327
1.23
0.59
5.7
2.8
1.4
1.7
mmol/l
1.22
40
313
12
173
0.69
0.57
1.2
1.5
—
—
—
0
0
5
87
0.57
0.56
1.0
1.1
—
—
—
0
0
5
87
0.57
0.56
1.0
1.1
—
—
—
0
0
5
87
0.57
0.56
1.0
1.1
—
—
—
0
0
181
1964
0.91
0.56
1.2
1.2
17.7
15.9
u/ml
0.07
45
751
23
296
0.77
0.55
4.1
3.3
36.5
30.6
mg/l
0.27
18
189
6
96
0.62
0.52
1.3
3.3
13.1
13.2
%
—
6
96
19
145
1.31
0.49
1.3
1.4
—
—
—
0
0
5
84
0.59
0.45
1.0
1.2
—
—
—
0
0
5
84
0.59
0.45
1.0
1.2
—
—
—
0
0
34
283
1.21
0.45
1.2
1.1
—
—
—
0
0
24
192
1.25
0.45
2.0
1.5
81.4
65.4
%
2.06
16
118
11
78
1.41
0.43
1.5
1.1
60.3
35.0
mg/l
0.93
11
68
5
31
1.61
0.43
1.0
1.1
—
—
—
0
0
5
31
1.61
0.43
1.8
1.5
0.4
0.4
ug/l
—
5
17
8
57
1.41
0.42
1.1
1.2
—
—
—
0
0
10
139
0.72
0.42
1.5
1.8
—
—
—
0
0
5
34
1.47
0.40
1.4
1.2
124.6
113.5
%
—
5
29
26
214
1.22
0.39
1.0
1.1
1.7
108.3
iu/ml
—
9
39
5
35
1.43
0.39
1.0
1.4
—
—
—
0
0
5
35
1.43
0.39
1.6
1.1
—
—
—
0
0
193
1815
1.07
0.39
4.4
5.0
30.3
32.8
%
2.60
136
1183
9
69
1.31
0.37
1.3
1.0
—
—
—
0
0
6
42
1.43
0.35
1.0
1.2
—
—
—
0
0
6
43
1.40
0.35
1.2
1.1
680.5
1568.0
miu/ml
—
6
43
53
471
1.13
0.34
1.1
1.2
—
—
—
0
0
20
163
1.23
0.34
1.2
1.2
3.1
3.2
u/ml
—
7
60
34
293
1.16
0.33
2.7
3.2
0.8
0.8
nmol/l
0.36
28
233
15
118
1.27
0.33
1.1
1.1
—
78.3
—
0
6
151
1418
1.07
0.33
2.2
2.4
6.3
8.1
ug/l
0.52
135
1251
37
322
1.15
0.32
1.1
1.2
3.7
3.7
u/ml
—
7
47
19
155
1.23
0.32
1.2
1.2
4.6
7.7
u/ml
—
9
75
35
304
1.15
0.32
2.1
1.5
0.9
0.9
nmol/l
0.29
30
247
36
410
0.88
0.30
2.1
1.8
—
—
—
0
0
21
176
1.20
0.29
1.6
1.4
—
—
—
0
0
9
116
0.77
0.27
1.4
1.8
—
—
—
0
0
10
77
1.30
0.26
1.3
1.0
378.3
257.6
mg/l
—
10
70
5
74
0.67
0.26
1.2
1.0
—
—
—
0
0
12
148
0.81
0.24
2.0
1.3
78834.3
114676.2
e6/l
—
7
105
32
284
1.13
0.23
1.5
1.3
919.1
624.5
e6/l
0.13
24
236
32
284
1.13
0.23
1.5
1.3
98.7
37.0
e6/l
0.29
24
227
17
143
1.19
0.23
1.2
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
0
12
0.00
0.21
0.0
1.4
—
9.8
—
0
12
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
212
2049
1.04
0.19
1.2
1.3
39.7
38.2
iu/ml
0.04
64
631
18
157
1.15
0.17
1.0
1.1
—
—
—
0
0
31
282
1.10
0.16
1.3
1.3
—
—
—
0
0
49
463
1.06
0.12
1.3
1.5
—
—
—
0
0
136
1323
1.03
0.11
1.6
1.8
1.5
1.6
%
1.33
115
1138
6
54
1.11
0.09
1.0
1.1
—
—
—
0
0
6
54
1.11
0.09
3.0
4.0
—
—
—
0
0
50
522
0.96
0.08
1.3
1.6
—
—
—
0
0
48
500
0.96
0.07
1.0
1.0
—
—
—
0
0
11
99
1.11
0.06
1.0
1.0
—
—
—
0
0
37
384
0.96
0.05
1.9
1.6
13483.1
13701.8
e6/l
0.02
26
280
17
180
0.94
0.04
1.1
1.0
—
—
—
0
0
1299
12971
1.01
0.03
4.7
4.8
1.3
1.4
mmol/l
22.10
1162
11835
1257
12555
1.01
0.02
4.2
4.3
1.5
1.3
mmol/l
13.50
1121
11356
1308
13083
1.00
0.00
4.8
4.9
4.4
4.5
mmol/l
3.62
1185
12028
1339
13385
1.00
0.00
5.2
5.5
2.6
2.6
mmol/l
2.81
1194
12251
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
2.4
—
2.6
—
0
5
0
5
0.00
0.00
0.0
1.2
—
7.7
—
0
5
9
95
0.95
0.00
1.6
1.4
—
55.7
—
0
7
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
5
55
0.91
0.00
1.2
1.2
368.2
248.7
iu/ml
—
5
55
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_KIDNEY_CLEAR_CELL_CARCINOMA_EXALLC – Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)
GWS hits: 3
This endpoint is excluded (different definition than used in FinnGen).